ABOUT THIS EVENT

Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, rings the Nasdaq Closing Bell remotely from across the country.

Ankit Mahadevia, MD, President & CEO, rings the Closing Bell alongside the Company’s team in a virtual bell ringing ceremony.